NCT06506435

Brief Summary

The purpose of this research study is to investigate the impact of virtual reality experiences on individuals undergoing radiotherapy, aiming to assess whether this immersive technology can reduce anxiety and enhance patient overall treatment satisfaction. By comparing different virtual reality techniques and a standard informational video, the study seeks to identify optimal strategies for leveraging virtual reality to improve the patient experience during radiotherapy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable anxiety

Timeline
7mo left

Started Dec 2024

Typical duration for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Dec 2024Dec 2026

First Submitted

Initial submission to the registry

July 11, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 17, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

December 4, 2024

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

December 19, 2025

Status Verified

December 1, 2025

Enrollment Period

2.1 years

First QC Date

July 11, 2024

Last Update Submit

December 12, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Level of Anxiety measured by scores on the State-Trait Anxiety Inventory (STAI)

    The State-Trait Anxiety Inventory (STAI) is a brief and widely used self-assessment tool validated to measure anxiety in individuals undergoing medical therapy or other stressful experiences. The scale consists of 20 items, with separate scales for trait and state. Scores on the Likert scale, ranging from 0 to 4, provide an assessment of symptom severity in patients dealing with various medical conditions (state) as well as baseline status (trait). Higher scores indicate higher levels of anxiety.

    Baseline, up to 2 weeks

Secondary Outcomes (3)

  • Change in Level of Anxiety measured by scores on the State-Trait Anxiety Inventory (STAI)

    Baseline, up to 8 weeks

  • Change in Radiation Oncology Knowledge Assessment Survey (ROKAS)

    baseline, up to 1 day (after intervention)

  • Change in Health-Related Quality of Life measured by the Functional Assessment of Cancer Therapy-General (FACT-G) Questionnaire

    Baseline, up to 8 weeks

Study Arms (3)

Informational Video

ACTIVE COMPARATOR

Participants in this group will watch a two-dimensional (2D) informational video that explains the radiation treatment process. Total participation is up to 8 weeks.

Behavioral: Two Dimensional (2D) Informational Video

Virtual Reality: 1st Person Perspective

EXPERIMENTAL

Participants in this group will have a virtual reality experience presented from a first-person perspective. Participants will wear a Meta Quest Pro virtual reality headset, immersing themselves in a scenario that replicates the radiation treatment process. Total participation is up to 8 weeks.

Behavioral: First-Person Virtual Reality Video

Virtual Reality: 3rd Person Perspective

EXPERIMENTAL

Participants in this group will wear a Meta Quest Pro virtual reality headset and use virtual reality to observe the radiation treatment scenario from a standing position within the room, enabling them to witness both the CT scan and radiation machine from an external viewpoint. Total participation is up to 8 weeks.

Behavioral: Third-Person Virtual Reality Video

Interventions

A 30-minute informational video. The two dimensional (2D) video provides information about the radiotherapy process. Participants will receive this one-time intervention in-person, prior to treatment.

Informational Video

A 30-minute virtual reality video, experienced through a headset, provides an immersive portrayal of the radiotherapy process from a third-person perspective. Participants will receive this one-time intervention in-person, prior to treatment.

Virtual Reality: 3rd Person Perspective

A 30-minute virtual reality video, experienced through a headset, provides an immersive portrayal of the radiotherapy process from a first-person perspective. Participants will receive this one-time intervention in-person, prior to treatment.

Virtual Reality: 1st Person Perspective

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Histologically proven cancer
  • ≥18 years of age
  • Able to speak and read English and/or Spanish
  • Receiving radiotherapy at the University of Miami

You may not qualify if:

  • Prior radiation therapy
  • Pregnant or nursing women
  • Men or women of childbearing potential who are unwilling to employ adequate contraception
  • Patients unable to consent or are prisoners
  • Participants with impaired decision-making capacity
  • Any serious illness or medical condition that would compromise patient safety during virtual reality as judged by the treating physician
  • Unwilling or unable to watch virtual reality video
  • Unwilling to fill out survey forms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Miami

Miami, Florida, 33136, United States

RECRUITING

MeSH Terms

Conditions

Anxiety DisordersNeoplasms

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Benjamin J Rich, MD

    University of Miami

    PRINCIPAL INVESTIGATOR
  • Crystal Chen, PhD

    University of Miami

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Benjamin J Rich, MD

CONTACT

Crystal Chen, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Clinical

Study Record Dates

First Submitted

July 11, 2024

First Posted

July 17, 2024

Study Start

December 4, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

December 19, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations